WAM
ENSC icon

Wolverine Asset Management’s Ensysce Biosciences ENSC Stock Holding History

Wolverine Asset Management’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$16 – 1849
2023
Q3 		$16 Hold
1
– – ﹤0.01% 1859
2023
Q2 		$21 Hold
1
– – ﹤0.01% 1785
2023
Q1 		$58 Hold
1
– – ﹤0.01% 1832
2022
Q4 		$112 Hold
1
– – ﹤0.01% 2053
2022
Q3 		$1K Hold
1
– – ﹤0.01% 2316
2022
Q2 		$4K Hold
1
– – ﹤0.01% 2143
2022
Q1 		$5K Hold
1
– – ﹤0.01% 2011
2021
Q4 		$16K Hold
1
– – ﹤0.01% 1768
2021
Q3 		$8K Buy
+1
New +$19.5K ﹤0.01% 1794

Other funds holding ENSC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PMFA
Plante Moran Financial Advisors Southfield, Michigan $2.15B AUM 22.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wolverine Asset Management's ENSC Position: Q4 2023 in Review

Wolverine Asset Management sold out of Ensysce Biosciences (ENSC) in Q4 2023, closing a stake of 1 share — an estimated $16 sold.

Wolverine Asset Management first reported a position in ENSC in Q3 2021 and held it in 9 quarters. The position peaked at $16K in Q4 2021. 8 funds tracked by Wall St. Rank hold ENSC as of Q4 2023.

  • Wolverine Asset Management reported no remaining Ensysce Biosciences position as of Q4 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 1 Ensysce Biosciences share in Q4 2023, an estimated $16.
  • Wolverine Asset Management first reported a position in Ensysce Biosciences in Q3 2021 and held it in 9 quarters.
  • Wolverine Asset Management's Ensysce Biosciences position peaked at $16K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.